Posted: 7 October Cartherics, a biotechnology company developing immune cell therapies for the treatment of cancer, announced that it has been granted US patent 11,400,145, entitled “Genetically modified cells and uses thereof”. This patent provides a proprietary position…
Future You, an initiative from the Australian Government’s Women in STEM Ambassador, Professor Lisa Harvey-Smith, has launched its Pathfinders series to help children aged 8 to 12 understand and explore pathways to exciting and rewarding STEM careers. The…
Posted: 5 October Fast Track designation has been granted by the US FDA for efti in combination with pembrolizumab in 1st line non-small cell lung cancer • Based on the encouraging Phase II clinical data for PD-L1 all-comers…
Posted: 4 October Part of the Australasian College of Health Service Management (ACHSM), Health Leader TV is a leading and trusted source of health service management information across the Australasian region. They provide best practice information, cutting-edge research…
Posted: 3 October Aculeus Therapeutics is a life sciences company focused on discovering and developing novel immunotherapies to treat a range of serious diseases. Today, Aculeus announced that it has initiated Investigational New Drug, or IND-enabling, studies for…
Posted: 27 September The funding from the Medical Research Future Fund (MRFF) Genomics Health Futures Mission will support research to harness the full potential of genomic data to improve diagnosis and inform clinical care for all patients who…
Posted: 27 September Cartherics, a biotechnology company developing immune cell therapies for the treatment of cancer, together within partner institutions, has received $5.4M Medical Research Futures Fund (MRFF) grant to develop a new approach to enhance cancer therapy…
Posted: 26 September Immutep Limited, a biotechnology company developing novel LAG-3 related immunotherapy treatments for cancer and autoimmune diseases, is pleased to announce it has received a A$2,693,046 research and development (R&D) tax incentive payment in cash from…
Posted: 14 September The longstanding relationship between 4DMedcial and its primary research and academic partner, the University of Melbourne, has been formalised through signing of a Memorandum of Understanding (MoU). The two organisations collaborate in a number of…
Posted: 8 September 2022 Melbourne, Australia & San Diego, USA: Global MedTech start-up Nutromics has raised an additional US $14 million for its wearable diagnostic platform. This transformative funding is key to Nutromics’ continued expansion across Australia and…
Posted: 6 September 2022 Expansion of the efti clinical development pipeline with a new Phase II setting Efti Phase II trial awarded €1.5M (~A$2.2M) in funding as part of the Polish Medical Research Agency program funded by the…
Posted: 1 September 2022 Dr. Glenn Haifer and Ampersand Capital Partners Acquire Australian Biologics CDMO Luina Bio, Rebranding Company as AcuraBio Brisbane, Australia – 31 August 2022 – AcuraBio (formerly Luina Bio), a leading Australian biopharmaceutical CDMO, has been…